(Q35627610)

9 August 2017

1 reference

title

Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease? (English)

1 reference

chronic obstructive pulmonary disease

9 August 2017

main subject

1 reference

Richard Wood-Baker

1

1 reference

9 August 2017

language of work or name

1 reference

1 January 2003

1 reference

Treatments in Respiratory Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

451-458

1 reference

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

The pathology of smoking-related lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Mannheim classification of nongenomically initiated (rapid) steroid action(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

The Effects of Bronchodilators on Pulmonary Ventilation and Diffusion in Asthma and Emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

BRONCHODILATORS AND CORTICOSTEROIDS IN CHRONIC BRONCHITIS AND EMPHYSEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

The Response of Patients with "Idiopathic" Obstructive Pulmonary Disease and "Allergic" Obstructive Bronchitis to Prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Response to corticosteroids in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Corticosteroids in Chronic Bronchitis and Pulmonary Emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Adverse effects of corticosteroid therapy for COPD. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Osteoporosis--emerging consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

A Controlled Study of the Effect of Prednisone on Air-Flow Obstruction in Severe Pulmonary Emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256672

21 January 2018

Identifiers

DOI

10.1007/BF03256672

1 reference

9 August 2017

1 reference